Loader

Pathways

PathWhiz ID Pathway Meta Data

PW176124

Pw176124 View Pathway
metabolic

Protriptyline Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Protriptyline are predicted with biotransformer.

PW132492

Pw132492 View Pathway
metabolic

Proxibarbal Drug Metabolism

Homo sapiens
Proxibarbal is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Proxibarbal passes through the liver and is then excreted from the body mainly through the kidney.

PW146622

Pw146622 View Pathway
drug action

Proxibarbal Drug Metabolism Action Pathway

Homo sapiens

PW000909

Pw000909 View Pathway
metabolic

PRPP Biosynthesis

Escherichia coli
The biosynthesis of phosphoribosyl pyrophosphate begins as a product of the pentose phosphate and D-ribose 5-phosphate interaction. When catalyzed with a phosphopentomutase, the product is a ribose 1-phosphate. Ribose 1-phosphate can interact spontaneously with ATP resulting in a release of hydrogen ion, ADP and a ribose 1,5-biphosphate. Ribose 1,5-biphosphate is then phosphorylated through a ribose 1,5-bisphosphokinase resulting in the release of ADP and phosphoribosyl pyrophosphate. Phosphoribosyl pyrophosphate will then participate in the purine nucleotides de novo biosynthesis pathway. Alternatively pentose phosphate and D-ribose 5-phosphate's interaction can be phosphorylated through an ATP driven ribose-phosphate diphosphokinase resulting in a release of a hydrogen ion, an AMP and a phosphoribosyl pyrophosphate which will again participate in the purine nucleotides de novo biosynthesis pathway.

PW122417

Pw122417 View Pathway
metabolic

PRPP Biosynthesis

Saccharomyces cerevisiae
The biosynthesis of phosphoribosyl pyrophosphate begins with a product of the pentose phosphate, D-ribose 5-phosphate interact with a phosphopentomutase resulting in a Ribose 1-phosphate or it can be phosphorylated through an ATP driven ribose-phosphate diphosphokinase resulting in a release of a hydrogen ion, an AMP and a phosphoribosyl pyrophosphate. The latter compound is then involved in the purine nucleotides de novo biosynthesis pathway. Ribose 1-phosphate can interact spontaneously with ATP resulting in a release of hydrogen ion, ADP and a ribose 1,5-biphosphate. The latter compound is then phosphorylated through a ribose 1,5-bisphosphokinase resulting in the release of ADP and phosphoribosyl pyrophosphate. The latter compound is then involved in the purine nucleotides de novo biosynthesis pathway.

PW128663

Pw128663 View Pathway
drug action

Prucalopride Action Pathway

Homo sapiens
Prucalopride acts as a selective stimulator of the 5-HT4 receptors while having no interaction with hERG channel or 5-HT1 receptors which reduces significantly the cardiovascular risk found in other similar drugs. 5-HT4 receptors can be found throughout the gastrointestinal tract primarily in smooth muscle cells, enterochromaffin cells, and myenteric plexus. Its activation produces the release of acetylcholine which is the major excitatory neurotransmitter in the GI tract. Hence, prucalopride stimulates motility by interacting specifically with 5-HT4 receptors in the GI tract which causes a release of acetylcholine and further contraction of the muscle layer of the colon and relaxation of the circular muscle layer leading to the propulsion of luminal content. Prucalopride is indicated for the treatment of chronic idiopathic constipation (CIC) in adults.

PW145717

Pw145717 View Pathway
drug action

Prucalopride Drug Metabolism Action Pathway

Homo sapiens

PW124237

Pw124237 View Pathway
metabolic

Prueba

Homo sapiens
Prueba de la prueba de la prueba

PW124244

Pw124244 View Pathway
metabolic

Prueba 2

Homo sapiens

PW124320

Pw124320 View Pathway
metabolic

prueba 50000

Homo sapiens